178 related articles for article (PubMed ID: 34438446)
21. Involvement of ligand occupancy in Insulin-like growth factor-I (IGF-I) induced cell growth in osteoblast like MC3T3-E1 cells.
Kim SK; Kwon JY; Nam TJ
Biofactors; 2007; 29(4):187-202. PubMed ID: 18057550
[TBL] [Abstract][Full Text] [Related]
22. IGFBP7 is associated to prognosis and could suppress cell survival in cholangiocarcinoma.
Yue C; Yang M; Tian Q; Mo F; Peng J; Ma Y; Huang Y; Wang D; Wang Y; Hu Z
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):817-825. PubMed ID: 29991293
[TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factor (IGF) signaling requires αvβ3-IGF1-IGF type 1 receptor (IGF1R) ternary complex formation in anchorage independence, and the complex formation does not require IGF1R and Src activation.
Fujita M; Takada YK; Takada Y
J Biol Chem; 2013 Feb; 288(5):3059-69. PubMed ID: 23243309
[TBL] [Abstract][Full Text] [Related]
24. IGF1/IGF1R and microRNA let-7e down-regulate each other and modulate proliferation and migration of colorectal cancer cells.
Li Z; Pan W; Shen Y; Chen Z; Zhang L; Zhang Y; Luo Q; Ying X
Cell Cycle; 2018; 17(10):1212-1219. PubMed ID: 29886785
[TBL] [Abstract][Full Text] [Related]
25. Human neuroblastoma cells use either insulin-like growth factor-I or insulin-like growth factor-II in an autocrine pathway via the IGF-I receptor: variability of IGF, IGF binding protein (IGFBP) and IGF receptor gene expression and IGF and IGFBP secretion in human neuroblastoma cells in relation to cellular proliferation.
Kiess W; Koepf G; Christiansen H; Blum WF
Regul Pept; 1997 Sep; 72(1):19-29. PubMed ID: 9404729
[TBL] [Abstract][Full Text] [Related]
26. Regulation of human dermal papilla cell production of insulin-like growth factor binding protein-3 by retinoic acid, glucocorticoids, and insulin-like growth factor-1.
Hembree JR; Harmon CS; Nevins TD; Eckert RL
J Cell Physiol; 1996 Jun; 167(3):556-61. PubMed ID: 8655609
[TBL] [Abstract][Full Text] [Related]
27. Insulin-like growth factors stimulate the release of insulin-like growth factor-binding protein-3 (IGFBP-3) and degradation of IGFBP-4 in nonsmall cell lung cancer cell lines.
Noll K; Wegmann BR; Havemann K; Jaques G
J Clin Endocrinol Metab; 1996 Jul; 81(7):2653-62. PubMed ID: 8675593
[TBL] [Abstract][Full Text] [Related]
28. Insulin-like growth factors in endometrial function.
Rutanen EM
Gynecol Endocrinol; 1998 Dec; 12(6):399-406. PubMed ID: 10065165
[TBL] [Abstract][Full Text] [Related]
29. IGF1R Derived PI3K/AKT Signaling Maintains Growth in a Subset of Human T-Cell Acute Lymphoblastic Leukemias.
Gusscott S; Jenkins CE; Lam SH; Giambra V; Pollak M; Weng AP
PLoS One; 2016; 11(8):e0161158. PubMed ID: 27532210
[TBL] [Abstract][Full Text] [Related]
30. Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily.
Kim HS; Nagalla SR; Oh Y; Wilson E; Roberts CT; Rosenfeld RG
Proc Natl Acad Sci U S A; 1997 Nov; 94(24):12981-6. PubMed ID: 9371786
[TBL] [Abstract][Full Text] [Related]
31. IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms.
Mohan S; Baylink DJ
J Endocrinol; 2002 Oct; 175(1):19-31. PubMed ID: 12379487
[TBL] [Abstract][Full Text] [Related]
32. Insulin-like growth factors in human breast cancer.
Ellis MJ; Jenkins S; Hanfelt J; Redington ME; Taylor M; Leek R; Siddle K; Harris A
Breast Cancer Res Treat; 1998; 52(1-3):175-84. PubMed ID: 10066081
[TBL] [Abstract][Full Text] [Related]
33. Activation of the insulin-like growth factor-1 receptor induces resistance to epidermal growth factor receptor antagonism in head and neck squamous carcinoma cells.
Jameson MJ; Beckler AD; Taniguchi LE; Allak A; Vanwagner LB; Lee NG; Thomsen WC; Hubbard MA; Thomas CY
Mol Cancer Ther; 2011 Nov; 10(11):2124-34. PubMed ID: 21878657
[TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor (IGF) system components in human prostatic cancer cell-lines: LNCaP, DU145, and PC-3 cells.
Kimura G; Kasuya J; Giannini S; Honda Y; Mohan S; Kawachi M; Akimoto M; Fujita-Yamaguchi Y
Int J Urol; 1996 Jan; 3(1):39-46. PubMed ID: 8646598
[TBL] [Abstract][Full Text] [Related]
35. Cellular actions of insulin-like growth factor binding proteins.
Ferry RJ; Katz LE; Grimberg A; Cohen P; Weinzimer SA
Horm Metab Res; 1999; 31(2-3):192-202. PubMed ID: 10226802
[TBL] [Abstract][Full Text] [Related]
36. Insulin-like growth factor binding proteins: new proteins, new functions.
Ferry RJ; Cerri RW; Cohen P
Horm Res; 1999; 51(2):53-67. PubMed ID: 10352394
[TBL] [Abstract][Full Text] [Related]
37. Classifying the adverse mitogenic mode of action of insulin analogues using a novel mechanism-based genetically engineered human breast cancer cell panel.
ter Braak B; Siezen CL; Kannegieter N; Koedoot E; van de Water B; van der Laan JW
Arch Toxicol; 2014 Apr; 88(4):953-66. PubMed ID: 24464500
[TBL] [Abstract][Full Text] [Related]
38. Novel aspects of the insulin-like growth factor binding proteins.
Wetterau LA; Moore MG; Lee KW; Shim ML; Cohen P
Mol Genet Metab; 1999 Oct; 68(2):161-81. PubMed ID: 10527667
[TBL] [Abstract][Full Text] [Related]
39. Modulation by retinoic acid of insulin-like growth factor (IGF) and IGF binding protein expression in human SK-N-SH neuroblastoma cells.
Babajko S; Binoux M
Eur J Endocrinol; 1996 Apr; 134(4):474-80. PubMed ID: 8640300
[TBL] [Abstract][Full Text] [Related]
40. Insulin-like growth factor binding protein 7 modulates estrogen-induced trophoblast proliferation and invasion in HTR-8 and JEG-3 cells.
Liu ZK; Liu HY; Fang WN; Yang Y; Wang HM; Peng JP
Cell Biochem Biophys; 2012 May; 63(1):73-84. PubMed ID: 22383111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
